First Impressions: Taiwan
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that is the envy of its neighbours. Here, three country managers for…
Patrick is the managing editor of PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 40 country reports and is a fluent Mandarin speaker.
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that is the envy of its neighbours. Here, three country managers for…
With the recent publication of Ten years on: Measuring the Return from Pharmaceutical Innovation 2019, PharmaBoardroom has teamed up with Deloitte to offer its readers an exclusive webinar on The Future of Biopharma. On 25th February…
Puerto Rico had to rebuild itself – in many cases quite literally – after the devastation wrought by Hurricane Maria in 2017. However, despite the havoc that Maria brought to…
Belying its small size, the Nordic nation of Sweden punches well above its weight in scientific innovation. Despite boasting a population of just 10 million and a marginal position on…
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an enviable reputation at the forefront of some of the most innovative trends shaping global…
PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: Thailand is available for download now. Thailand is in the midst of an economic transformation with healthcare at its heart. With four years…
In conversation at the FT Global Pharmaceutical and Biotechnology Conference in London,* an energetic Emma Walmsley discussed the strategic and cultural shifts she has implemented in her two and a…
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied career at MSD in a wide variety of geographies. Canada’s…
Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research throughout Latin America on neglected diseases. This agreement establishes an exchange…
Indian generics powerhouse Dr. Reddy’s has prioritized biosimilars as a key component of the global organization’s ongoing transition into a specialty pharma company. As one of the first companies…
Worldwide, severe side effects from classic medicine are becoming a health risk in themselves, often misdiagnosed as symptoms of other problems, resulting in further prescriptions, further side effects and unanticipated drug interactions;…
LIFEPharma, a subsidiary of UAE-based VPS Healthcare, has signed a Dh 200 million (USD 55 million) deal with Canada’s Apotex to produce 120 million generic tablets and medicines for Motor…
See our Cookie Privacy Policy Here
